
    
      Design

      The study is a national, multicenter, non-interventional, observational, prospective
      registry.

      Population

      Patients older than 18 years old of age, have acute coronary syndrome or percutaneous
      coronary intervention electively and with available admission hemoglobin, white blood cell
      and creatine clearance data will be enrolled for Precise-DAPT,and Patients older than 18
      years old of age and completed 12 months of dual anti-platelet therapy without having
      hemorrhage and ischemic coronary event and with available data of age, history of smoking,
      presence of diabetes mellitus, history of percutaneous coronary intervention, paclitaxel
      eluting stent, stent diameter, history of myocardial infarction, saphenous vein graft
      intervention, ejection fraction or presence of heart failure. Patients that do not approve
      informed consent will be excluded.

      Aim

      This study is amid to investigate the demographic and clinical profile of patients with CAD
      and on dual anti-platelet therapy, mean precise -DAPT and DAPT scores of Turkey.
    
  